Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02261324
NCT02261324
Completed
Not Applicable

Is the Four Metre Gait Speed a Useful Outcome Measure in Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention?

Royal Brompton & Harefield NHS Foundation Trust1 site in 1 country560 target enrollmentStarted: December 2013Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcute Myocardial Infarction

Overview

Phase
Not Applicable
Status
Completed
Enrollment
560
Locations
1
Primary Endpoint
Mortality rate
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future cardiovascular events and death.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Any patient hospitalised with an acute myocardial infarction who has undergone primary percutaneous coronary intervention
  • •Capacity to consent
  • •Able to walk
  • •Age over 18 years

Exclusion Criteria

  • •Significant co-morbidities that would limit exercise capacity or make exercise unsafe (e.g. neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation)

Outcomes

Primary Outcomes

Mortality rate

Time Frame: 1 year

Secondary Outcomes

  • Occurrence of cardiovascular events(1 and 5 years)
  • Need for repeat revascularisation(1 and 5 years)
  • Health resource usage(1 and 5 years)
  • All-cause mortality(5 years)
  • Cardiovascular death(1 and 5 years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
The Predictive Ability of 4MGS in IPFIdiopathic Pulmonary Fibrosis
NCT02436278Royal Brompton & Harefield NHS Foundation Trust132
Completed
Not Applicable
Assessing the Reliability and Validity of 4-meter and 10-meter Walking TestStrokeGait, HemiplegicCerebral InfarctionCerebrovascular Disorders
NCT04919772Universitat Internacional de Catalunya20
Completed
Not Applicable
Efficacy of 4-metre gait speed in the patients with chronic interstitial pneumonia
JPRN-UMIN000021951Department of Respiratory Medicine, National Hospital Organization Ibarakihigashi National Hospital72
Completed
Not Applicable
Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
NCT02530736Royal Brompton & Harefield NHS Foundation Trust120
Not yet recruiting
Not Applicable
Gait Speed at Discharge as a Marker for ReadmissionAll Disease That May Require Acute Hospitalization Except for Phsychiatric Disease
NCT03049865Karolinska University Hospital1,000